Search PubMed⌕ Search

Biomedical subjects

C Chan

Publications and source records attributed to C Chan.

276 records · Page 16Linked to original sources
PubMedDate not supplied

A new class of leukotriene biosynthesis inhibitor: the development of MK-0591.

The evolution of MK-0591 (3-[1-(4-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-ylmethoxy+ ++)indol-2-yl]- 2,2-dimethylpropanoic acid), 12, a potent, orally active leukotriene biosynthesis inhibitor is described. MK-0591 is currently undergoing clinical evaluation as a potential agent for the treatment of asthma and inflammatory bowel disease. It acts through a novel mechanism by a specific interaction with a membrane protein, 5-lipoxygenase activating protein (FLAP), which has been shown to be essential for LT synthesis in inflammatory cells. A brief comparison of its biological activity with that of its progenitors MK-886 and L-674,636 is described.

5-Lipoxygenase-Activating Proteins↗
PubMedDate not supplied

[7 cases of carcinoma of the distal choledochus].

Seven patients with carcinoma of the lower third of the extrahepatic bile duct over a twenty year period, were analyzed with emphasis to the presentation, laboratory, surgical findings, histology and outcome. There were four males and three females. The mean age was 59 years (range 53 to 68). All patients presented jaundice, abdominal pain and weight loss. Serum bilirubin levels were over 5 mg/dL in six patients (86%). The most useful diagnostic studies were endoscopic cholangiography, percutaneous cholangiography and computed tomography. All patients underwent a Whipple procedure. There was no operative mortality. In the long term follow-up, three patients were free of disease, and four had died. Tumor recurrence was high (43%) in spite of the curative resection.

Adenocarcinoma↗
PubMedDate not supplied

[Pancreatoduodenectomy in the treatment of carcinoma of Vater's ampulla].

OBJECTIVE: To analyze clinical characteristics, diagnostic methods, intraoperative findings, morbidity & mortality and outcome of a series of patients with ampullary adenocarcinoma. DESIGN: Retrospective analysis. SETTING: Tertiary-care medical center. PATIENTS: Thirty four consecutive patients who underwent radical resection between 1960 and 1992. RESULTS: The most frequent findings were jaundice (91%), weight loss (44%) and palpable gallbladder (42%). Thirty-three patients (97%) underwent Whipple resection and one total pancreatectomy (3%). The postoperative mortality was 15%. Overall survival at 1, 5, 10 and 14 years was 67, 36, 25 and 17% respectively. Fourteen patients died of tumor recurrence developed more than five years after the resection. CONCLUSION: Radical resection for ampullary carcinoma remains the procedure of first choice in these patients.

Adenocarcinoma↗
PubMedDate not supplied

[Metastatic disease of the liver: surgical perspective].

Approximately half of patients with colorectal cancer will develop hepatic metastases and it is estimated that up to 10% of that group will have resectable liver disease. Surgical resection remains the first line treatment option of metastatic liver tumors and has yielded a 20 to 40% five year survival rate. Selection of appropriate patients for resection is critical to a successful outcome. The best results are obtained in patients with isolated metastases. Factors that are associated with a poorer results are the presence of four or more lesions or a surgical margin less than 1 cm. Endocrine metastases can be resected in a palliative fashion but each case has to be individualized. This is also true for non colorectal-nonendocrine metastases. For this tumors the experience is anecdotal and confined to limited reported series. Adjuvant treatment (infusional chemotherapy and chemoembolization) can also have a role in treatment as well as cryotherapy.

Antimetabolites, Antineoplastic↗
PubMedDate not supplied

[Small-diameter portosystemic shunts: indications and limitations].

Low diameter porto-systemic shunts for the treatment of portal hypertension bleeding have emerged as a consequence of the technical development of vascular grafts (PTFE) that allow the use of a narrow lumen. The experience with this kind of operation at the Instituto Nacional de la Nutrición Salvador Zubirán, Mexico City during a 6-year period is reported. There were twenty-seven patients with good liver function (Child-Pugh A-B) were operated or electively, average Age 47.5 years (range 17-71), twenty three patients with liver cirrhosis, one with portal fibrosis and three with idiopathic portal hypertension. Operative mortality: 4%. Rebleeding: 14%. Postoperative encephalopathy was observed in 14 of 27, three of them being grade III-IV (11%). In the remaining 11 cases, it was mild and easily controlled. Postoperative angiography showed shunt patency in 81% of the cases; in 33% of the cases, portal vein diameter reduction was shown, as well as two cases with portal vein thrombosis. In 77% of the cases, adequate postoperative quality of life was observed. Survival (Kaplan-Meier): 86% at 12 months and 56% at 60 months. These kinds of shunts are a good alternate choice for patients considered for surgery, in which other portal blood flow preserving procedures (selective shunts, devascularization with transection) are not feasible.

Adolescent↗